Laboratory Management & Operations

So let me see if I have this straight -- Epic has hired a lobbying firm to lobby Congress to counter stories they are not interoperable with other systems when in fact they are?  And the people you are going to take this message to is...

Join ASI in booth # 223 at CAP’14 – THE Pathologists’ Meeting Come see ASI’s GenASIs HiPath, the latest Pathology Quantitative Diagnostic Aid, providing solutions for any sized lab! Ask questions from our experts, see a demo and get...

Somehow in the excitement of greater than 52% cuts to the technical component of the biopsy code and an overall 30% reduction in reimbursement I missed this humorous song about pathology fee codes and decreasing reimbursement. A parody of...

Here it is – a simple, easy to perform, highly reproducible plan for manufacturer pre-market approval or laboratory self-validation for the intended use of endoscopic mucosal gastrointestinal biopsies. These specimens are extremely common...

New Webinar from The Dark Report — Wednesday, September 17, 2014 Our distinguished panel explains how the FDA’s draft guidance is a road map that labs can follow immediately to optimize how the FDA treats their most important...

More positive news coming from Ventana with its CE Mark in the EU for routine pathology, including primary diagnosis.   New CE mark in the European Union extends application to routine pathology including primary diagnosis with human tissue...